Näytetään tulokset 1 - 10 / 9226
tulosta / sivu
Mitä julkaisutietoja palvelu sisältää?
Julkaisun nimi
Tekijät
Julkaisukanava
Vuosi
 Julkaisujen tiedon ikoni

Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer

Vertaisarvioitu
DOI
10.1038/s41391-018-0087-0
Murtola, Teemu J.; Talala, Kirsi; Kasurinen, Tatu V. J.; Taari, Kimmo; Tammela, Teuvo L. J.; Auvinen...
Prostate cancer and prostatic diseases2019 Julkaisujen tiedon ikoni

Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer

Vertaisarvioitu
DOI
10.1038/s41391-018-0089-y
Chattopadhyay, Subhayan; Hemminki, Otto; Försti, Asta; Sundquist, Kristina; Sundquist, Jan; Hemminki...
Prostate cancer and prostatic diseases2019 Julkaisujen tiedon ikoni

Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer

Vertaisarvioitu
DOI
10.1038/s41391-018-0123-0
Murtola, Teemu J.; Salli, Samueli M.; Talala, Kirsi; Taari, Kimmo; TammelaL, Teuvo L. J.; Auvinen, A...
Prostate cancer and prostatic diseases2019 Julkaisujen tiedon ikoni

Allopurinol and prostate cancer survival in a Finnish population-based cohort

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41391-022-00597-4
Kukko, Ville; Kaipia, Antti; Talala, Kirsi; Taari, Kimmo; Tammela, Teuvo L. J.; Auvinen, Anssi; Murt...
Prostate cancer and prostatic diseases2022 Julkaisujen tiedon ikoni

Allopurinol and the risk of prostate cancer in a Finnish population-based cohort

Vertaisarvioitu
DOI
10.1038/s41391-019-0129-2
Kukko, Ville; Kaipia, Antti; Talala, Kirsi; Taari, Kimmo; Tammela, Teuvo L. J.; Auvinen, Anssi; Murt...
Prostate cancer and prostatic diseases2019 Julkaisujen tiedon ikoni

Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41391-023-00740-9
Jones, Robert Hugh; Fizazi, Karim; James, Nicholas D.; Tammela, Teuvo L.; Matsubara, Nobuaki; Priou,...
Prostate cancer and prostatic diseases2023 Julkaisujen tiedon ikoni

Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users: A population-based cohort study

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41391-021-00351-2
Peltomaa, A. I.; Raittinen, P.; Talala, K.; Taari, K.; Tammela, T. L. J.; Auvinen, A.; Murtola, T. J...
Prostate cancer and prostatic diseases2021 Julkaisujen tiedon ikoni

A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells

Vertaisarvioitu
DOI
10.1038/pcan.2013.7
Lippolis, G.; Edsjo, A.; Stenman, U-H; Bjartell, A.
Prostate cancer and prostatic diseases2013 Julkaisujen tiedon ikoni

Prostate Cancer, Inflammation and Antioxidants

Vertaisarvioitu
DOI
10.5772/53296
Crohns, Marika; Westermarck, Tuomas; Atroshi, Faik
InTech2013 Julkaisujen tiedon ikoni

Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013:a population-based analysis

Vertaisarvioitu
DOI
10.1038/pcan.2016.36
Lahdensuo, Maija Kanerva; Rannikko, A.; Anttila, Veli-Jukka A; Erickson, A.; Patari-Sampo, A.; Rauti...
Prostate cancer and prostatic diseases2016

Serum cholesterol and prostate cancer risk in the Finnish randomized study of screening for prostate cancer

Vertaisarvioitu
DOI
10.1038/s41391-018-0087-0
2019

Impact of family history of cancer on risk and mortality of second cancers in patients with prostate cancer

Vertaisarvioitu
DOI
10.1038/s41391-018-0089-y
2019

Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer

Vertaisarvioitu
DOI
10.1038/s41391-018-0123-0
2019

Allopurinol and prostate cancer survival in a Finnish population-based cohort

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41391-022-00597-4
2022

Allopurinol and the risk of prostate cancer in a Finnish population-based cohort

Vertaisarvioitu
DOI
10.1038/s41391-019-0129-2
2019

Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41391-023-00740-9
2023

Prostate cancer prognosis after initiation of androgen deprivation therapy among statin users: A population-based cohort study

Vertaisarvioitu
Avoin saatavuus
DOI
10.1038/s41391-021-00351-2
2021

A high-density tissue microarray from patients with clinically localized prostate cancer reveals ERG and TATI exclusivity in tumor cells

Vertaisarvioitu
DOI
10.1038/pcan.2013.7
2013

Prostate Cancer, Inflammation and Antioxidants

Vertaisarvioitu
DOI
10.5772/53296
2013

Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005-2013:a population-based analysis

Vertaisarvioitu
DOI
10.1038/pcan.2016.36
2016